Arkolith/Insider Trading/EVLO/Form 4

Gill Simba

President & CEO, DirectorEvelo Biosciences, Inc. (EVLO) · full profile →Form 4 · filed May 10, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$460
Net Open-Market Flow
-$460
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2023Sell(S)4K$0.13$46059K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001694665-23-000051) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML